00882nam0-22003011i-450-99000654503040332120001010000654503FED01000654503(Aleph)000654503FED0100065450320001010d--------km-y0itay50------baitay-------001yyOptimal control theory and static optimization in economicsDaniel Leonard, Ngo Van LongCambridgeCambridge University Press1992.X, 353 p.23 cm330.01Leonard,Daniel231620Van Long,NgoITUNINARICAUNIMARCBK990006545030403321VI A 106417374FSPBCFSPBCOptimal control theory and static optimization in economics619327UNINAGEN0100900nam a2200265 i 450099100091148970753620020507103125.0951204s1969 us ||| | eng b10147135-39ule_instLE00639017ExLDip.to Fisicaita53(022)53.0.66621.3.1Roberge, J.461795Electronic components and measurements /J. Roberge and B. WedlockEnglewood Cliffs, NJ :Prentice-Hall,19691 v.Wedlock, B..b1014713521-09-0627-06-02991000911489707536LE006 53(022)+53.0.6 WED12006000003926le006-E0.00-l- 00000.i1017523427-06-02Electronic components and measurements186546UNISALENTOle00601-01-95ma -engus 0104340nam 2201201z- 450 991059507080332120231214133143.0(CKB)5680000000080822(oapen)https://directory.doabooks.org/handle/20.500.12854/92074(EXLCZ)99568000000008082220202209d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierDiagnostic or Therapeutic Strategies for Pregnancy ComplicationsBaselMDPI Books20221 electronic resource (238 p.)3-0365-4877-7 3-0365-4878-5 It is well known that pregnancy complications, including preeclampsia, preterm birth, stillbirth, and intrauterine growth restriction affect over 12% of all pregnancies worldwide. These complications negatively impact both maternal and neonatal health and have short- and long-term effects such as an increased risk of neurodevelopmental and cardiovascular diseases. Over the past decade, numerous groups have investigated the use of new and/or existing drugs to either prolong gestation, such as in cases of threatened preterm labour; alleviate hypertension in preeclampsia; or promote adequate blood flow and nutrient delivery to the placenta to facilitate growth in IUGR. The overarching goal has been to promote healthier pregnancies and neonatal health, but it has been difficult to translate this work into the clinical setting, with problems in terms of drug delivery, specificity, and importantly, the early diagnostic capacities for complications in pregnancy. This book focuses on the early detection, potential novel therapeutic targets, risk factors, maternal outcomes, and long-term consequences of this critical problem.Medicinebicsscultrasonographyelastographyuterine cervixterm pregnancyparturitiongenotypingpreeclampsiaMMP-9MMP-2SNPstocolyticpreterm birthpreterm laborneonateprematuritypregnancytherapeuticprogesteronefetussex as a biological variablesex differencespregnancy complicationsplacentaprenatal diagnosisfetal growth restrictionmiscarriagechorio-deciduitisgradeamnionitisacute histologic chorioamnionitisintra-amniotic inflammatory responsebeta-blockerendothelial dysfunctioncardiovascular diseasepregnancy lossimmunologyvascular endothelial growth factorgalectin-9interleukin-4proteomicsurinebiomarkersIBP4SHBGRPLNK cellssildenafilPDE5AVEGF-Aangiotensininfantnewbornfemaleabruptio placentaeApgar scorepregnant womengestational ageIL-1 blockadeanakinracanakinumabhumaninflammationfetal growth restriction (FGR)intra-uterine growth restriction (IUGR)SPINT1HAI-1stillbirthplacental insufficiencyhistopathologycardiovascular riskpostpartum screeningMedicineHeazell Alexanderedt1328470Girard SylvieedtHeazell AlexanderothGirard SylvieothBOOK9910595070803321Diagnostic or Therapeutic Strategies for Pregnancy Complications3038575UNINA